Assessment of wavelengths with skin tones for an implantable FRET-based glucose biosensor

Lydia E. Colvin; Ping Dong; A. Kristen Means; Melissa A. Grunlan; Gerard L. Coté

doi:10.1117/12.2509912

20 February 2019 Assessment of wavelengths with skin tones for an implantable FRET-based glucose biosensor

Lydia E. Colvin, Ping Dong, A. Kristen Means, Melissa A. Grunlan, Gerard L. Coté

Proceedings Volume 10885, Optical Diagnostics and Sensing XIX: Toward Point-of-Care Diagnostics; 108850Y (2019) https://doi.org/10.1117/12.2509912
Event: SPIE BiOS, 2019, San Francisco, California, United States

Abstract

Diabetes management is reliant on consistent and accurate monitoring. Low patient compliance for the standard finger prick test along with its intermittent nature may lead to undetected highs and lows. In 2014, poor glycemic control caused 207,000 hospitalizations from hyperglycemia and 245,000 hospitalizations from hypoglycemia in the US. The implementation of continuous glucose monitors (CGMs) can provide a more thorough illustration of blood glucose level fluctuations. Currently, there are several transcutaneous CGMs produced by Abbott, Dexcom, and Medtronic along with a fully implantable option by Eversense. Improvements to both the sensitivity and size of CGMs are being studied by our group through the development of a competitive binding, FRET-based, glucose biosensor that is fully implantable and probed optically with an external “watch-type” device. In previous work, our group has successfully developed an assay, but due to the near-UV excitation wavelength range, there are limitations in decreased skin penetration depth along with excess noise due to autofluorescence of the tissue. In this work, we investigated the FRET response through skin samples of both Blue (APTS) and near infrared (NIR) (Alexa Fluor 700 and 750) dyes. These dye samples were encapsulated within previously reported hollow, cylindrical, thermoresponsive hydrogel membranes and the fluorescence intensity signals were compared when placed beneath thin and thick (0.87 and 1.85 mm) rat skin samples. The FRET response of AF-700 and AF-700 was measured when placed beneath thicker skin samples of both lighter and dark pigmentations. The results indicate that the use of NIR dyes is needed to allow for a reasonable implantation depth for the implantable biosensor.

Citation Download Citation

Lydia E. Colvin, Ping Dong, A. Kristen Means, Melissa A. Grunlan, and Gerard L. Coté "Assessment of wavelengths with skin tones for an implantable FRET-based glucose biosensor", Proc. SPIE 10885, Optical Diagnostics and Sensing XIX: Toward Point-of-Care Diagnostics, 108850Y (20 February 2019); https://doi.org/10.1117/12.2509912

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available

Members: $17.00

Non-members: $21.00 ADD TO CART

PROCEEDINGS
7 PAGES

DOWNLOAD PAPER SAVE TO MY LIBRARY

GET CITATION

RIGHTS & PERMISSIONS

Get copyright permission Get copyright permission on Copyright Marketplace

KEYWORDS

Skin

Glucose

Biosensors

Fluorescence resonance energy transfer

Near infrared

Sensors

Tissues

Keywords/Phrases

Search In:

Publication Years